Grown Rogue International (GRUSF) Other Non-Current Liabilities (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Other Non-Current Liabilities of $768951.0 for Q1 2026, up 60.39% year-over-year from $479421.0 in Q1 2025, and down 93.85% quarter-over-quarter from $12.5 million in Q4 2025.
Grown Rogue International (GRUSF) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Grown Rogue International's Other Non-Current Liabilities history runs 15 years deep, the most recent figure standing at $768951.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 60.39% year-over-year to $768951.0; the TTM figure through Mar 2026 stood at $768951.0 (up 60.39% YoY), while the FY2025 annual figure was $12.5 million, up 149.73% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $768951.0, down from $12.5 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $657.6 billion in Q3 2025, with the low at $193195.5 in Q4 2024.
- The 5-year median for Other Non-Current Liabilities is $768951.0 (2026), against an average of $73.1 billion.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities sank 97.42% in 2024, then soared 6372.29% in 2025.
- Grown Rogue International's Other Non-Current Liabilities stood at $271042.4 in 2022, then surged by 2660.6% to $7.5 million in 2023, then tumbled by 97.42% to $193195.5 in 2024, then surged by 6372.29% to $12.5 million in 2025, then slumped by 93.85% to $768951.0 in 2026.
- Business Quant data shows GRUSF's Other Non-Current Liabilities at $768951.0 in Q1 2026, $12.5 million in Q4 2025, and $657.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.83 Mn |
| Mar 31, 2026 | 768,951.00 |
| Dec 31, 2025 | 12.50 Mn |
| Sep 30, 2025 | 657.63 Bn |
| Jun 30, 2025 | 657,627.00 |
| Mar 31, 2025 | 479,421.00 |
| Dec 31, 2024 | 193,195.51 |
| Dec 31, 2023 | 7.48 Mn |
| Jul 31, 2023 | 923,208.64 |
| Oct 31, 2022 | 271,042.35 |
| Aug 31, 2018 | 572,717.53 |
| May 31, 2018 | 583,997.90 |
| Feb 28, 2018 | 595,244.05 |
| Nov 30, 2017 | 597,802.38 |
| Aug 31, 2017 | 582,211.56 |
| May 31, 2017 | 2.19 Mn |
| Feb 28, 2017 | 2.23 Mn |
| Nov 30, 2016 | 2.22 Mn |
| Aug 31, 2016 | 2.26 Mn |
| May 31, 2016 | 3.40 Mn |